HIV News and Research

RSS

Burma needs AIDS funds

The charity Medecins Sans Frontieres (MSF) or Doctors Without Borders has urged international donors to make more money available to treat HIV/AIDS in Burma.

23 Feb 2012

Sustainable funding needed to reduce Burma's HIV, TB treatment gap

"While international attention focuses on Burma, [also known as Myanmar,] a health crisis in the country looms large," Joe Billiveau, operations manager of Medecins Sans Frontieres' (MSF) operational center in Amsterdam, writes in this opinion piece in Bangkok's Nation.

23 Feb 2012

Studies provide global perspective on condom use problems and errors

Problems with the correct use of the male condom, such as not wearing a condom throughout sex or putting it on upside down, are common in the U.S. and have become a major concern of public health officials. New research shows that countries around the world are facing similar challenges.

23 Feb 2012

Burma unable to expand HIV, TB treatment programs without more donor support, MSF report says

Approximately 85,000 HIV-positive people in Burma, also known as Myanmar, are in need of antiretroviral treatment (ART) and cannot access it "due to a lack of funding, despite renewed international engagement with the government amid a wave of political reform, according to a report released Wednesday" by the medical aid group Medecins Sans Frontieres (MSF), the Associated Press/CBS News reports.

23 Feb 2012

State roundup: Calif. HMO report cards, Ore. family planning bills challenged, Texas managed care

Gov. Corbett's new budget proposal would cost the city $42 million in mostly mental health and addiction treatment funding, but city officials say the impact will be worsened by ensuing needs for emergency shelter, child welfare, and other services. … The city Health Department faces an additional $7 million in state cuts. That would reduce the number of beds in the city nursing home and cost hospice beds for AIDS victims, officials said.

23 Feb 2012

International Microbicides Conference to take place from April 15-18

The biennial International Microbicides Conference is the premier gathering for those working on new approaches to HIV prevention and this year's conference in Sydney, Australia will place a strong emphasis on the role of community in both research and implementation of scientific findings. The conference will take place from April 15-18 at the Sydney Exhibition and Conference Centre located on the Darling Harbour waterfront.

23 Feb 2012

IDRI launches LEISH-F3 + GLA-SE Phase 1 trial for kala-azar

The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat diseases of poverty. The Phase 1 trial is taking place in Washington State, with a companion Phase 1 trial planned in India, an epicenter of the disease.

23 Feb 2012

Routine hepatitis C testing of the middle aged could save thousands of lives: CDC report

Increasing number of people are dying of damaged livers due to hepatitis C infection. Federal health officials are considering whether anyone born between 1945 and 1965 should get a one-time blood test to check if they are harboring the dangerous virus. Two-thirds of people with hepatitis C are in this age group, most unaware that a virus that takes a few decades to do its damage has festered since their younger days.

22 Feb 2012

March issue of BMJ's 'Sexually Transmitted Infections' focuses on HIV, health systems

Karen Grepin, assistant professor of global health policy at New York University's Robert F. Wagner Graduate School of Public Service, describes the March issue of BMJ's Sexually Transmitted Infections in this post in her "Global Health Blog."

22 Feb 2012

Russian government's censorship of websites with harm reduction methods for drug users helps fuel HIV epidemic, IPS reports

"A recent government crackdown on Russian media, particularly online information portals specializing in health tips and harm reduction methods for drug users, has sparked widespread public opposition, with critics claiming that the 'draconian silencing' of public health advocates could worsen an already perilous health situation in the country," Inter Press Service reports.

22 Feb 2012

Study reveals potential strength of different anti-HIV combination drugs

Using a mathematical formula that carefully measures the degree to which HIV infection of immune system cells is stalled by antiretroviral therapy, AIDS experts at Johns Hopkins have calculated precisely how well dozens of such anti-HIV drugs work, alone or in any of 857 likely combinations, in suppressing the virus. Results of the team's latest research reveal how some combinations work better than others at impeding viral replication, and keeping the disease in check.

19 Feb 2012

Shah says 'difficult choices' made in FY13 International Affairs budget request

In this post on USAID's "IMPACTblog," USAID Administrator Rajiv Shah says the FY 2013 International Affairs budget request "showcases President Obama's commitment to making smart, efficient investments to help those in the greatest need while helping to create economic opportunity and safeguarding American security." Despite

18 Feb 2012

WHO confirms recommendations regarding HIV, female hormonal contraceptives after review of studies

"A stakeholder consultation convened by the World Health Organization (WHO) in Geneva has reviewed recent epidemiological studies related to HIV transmission and acquisition by women using hormonal contraceptives," a UNAIDS press statement reports.

18 Feb 2012

AHF criticizes Obama administration for global AIDS budget

AIDS Healthcare Foundation (AHF) today criticized the Obama administration, which—in a shocking repudiation of nearly thirty years of progress against the global AIDS pandemic—last Monday unveiled a global AIDS budget that takes the unprecedented step of reducing AIDS funding by approximately $214 million in fiscal year 2013. Never before has a President sought to actually reduce America's commitment to fighting the AIDS epidemic globally.

18 Feb 2012

Study reveals immune mechanism for surveillance over EBV infection

Some 90 percent of people are exposed to the Epstein Barr virus (EBV) at some point in their life. Even though it is quickly cleared from the body, the virus can linger silently for years in small numbers of infected B cells.

18 Feb 2012

Russian NGOs fear fate of HIV harm-reduction programs as planned exit of Global Fund occurs

The Moscow Times examines a potential shift in Russia's public health priorities as programs funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria begin to phase out.

17 Feb 2012

State roundup: Settlements for mental health facilities lawsuits; Minn., Oregon insurers face scrutiny

But the survey underway in Prince George's County is intended to address a complex problem. Officials expect the data to give them a detailed look at the state of health and health care in the county, where conditions such as diabetes and heart disease are much more common than in the rest of the region and most of the state.

17 Feb 2012

U of A researcher discovers new vaccine against HCV

A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, who led the team that discovered the hepatitis C virus in 1989, announced his findings at the Canada Excellence Research Chairs Summit in Vancouver this afternoon. Currently, there are no vaccines against the disease available.

17 Feb 2012

Brandeis professor investigates wallpaper-like liner technology for tackling malaria

Can an innovative wallpaper-like liner help reduce the number of cases of malaria, and if so, will it be cost effective? Donald S. Shepard, a professor at the Schneider Institutes for Health Policy at the Heller School wants to know. And he has gotten the Bill and Melinda Gates Foundation to help. A grant, totaling nearly $500,000 over the next three years, will allow Shepard and collaborators to pursue their research in Kenya and Tanzania.

17 Feb 2012

New way to improve vaccines against cancer and infectious diseases

Research groups from Charité Universitätsmedizin Berlin and the University of Geneva have discovered a new way of improving vaccines against infectious diseases and for use in cancer therapies. Scientists have shown a basic new mechanism that stimulates the body's own alarm signals in case of viral infection to animate the immune system to maximum performance.

17 Feb 2012

HIV News and Research

Burma needs AIDS funds

Sustainable funding needed to reduce Burma's HIV, TB treatment gap

Studies provide global perspective on condom use problems and errors

Burma unable to expand HIV, TB treatment programs without more donor support, MSF report says

State roundup: Calif. HMO report cards, Ore. family planning bills challenged, Texas managed care

International Microbicides Conference to take place from April 15-18

IDRI launches LEISH-F3 + GLA-SE Phase 1 trial for kala-azar

Routine hepatitis C testing of the middle aged could save thousands of lives: CDC report

March issue of BMJ's 'Sexually Transmitted Infections' focuses on HIV, health systems

Russian government's censorship of websites with harm reduction methods for drug users helps fuel HIV epidemic, IPS reports

Study reveals potential strength of different anti-HIV combination drugs

Shah says 'difficult choices' made in FY13 International Affairs budget request

WHO confirms recommendations regarding HIV, female hormonal contraceptives after review of studies

AHF criticizes Obama administration for global AIDS budget

Study reveals immune mechanism for surveillance over EBV infection

Russian NGOs fear fate of HIV harm-reduction programs as planned exit of Global Fund occurs

State roundup: Settlements for mental health facilities lawsuits; Minn., Oregon insurers face scrutiny

U of A researcher discovers new vaccine against HCV

Brandeis professor investigates wallpaper-like liner technology for tackling malaria

New way to improve vaccines against cancer and infectious diseases

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News